Kronos Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	91.58	84.57	64.33	75.97	198.27	248.01
Short-Term Investments	8.16	27.85	108.67	162.21	141.24	165.05
Cash & Short-Term Investments	99.73	112.42	173	238.19	339.51	413.06
Cash Growth	-34.38%	-35.02%	-27.37%	-29.84%	-17.81%	348.08%
Other Receivables	-	-	-	-	0.82	0.61
Receivables	-	-	-	-	0.82	0.61
Prepaid Expenses	1.34	2.51	5.38	6.11	6.25	5.01
Other Current Assets	0.8	0.3	0.4	-	0.98	1.12
Total Current Assets	101.87	115.23	178.78	244.29	347.55	419.8
Property, Plant & Equipment	4.13	7	29.91	37.69	41.78	40.97
Long-Term Investments	-	-	1.99	9.76	-	49
Other Long-Term Assets	2.14	2.14	2.6	3.19	2.14	2.19
Total Assets	108.14	124.36	213.28	294.94	391.48	511.96
Accounts Payable	1.57	2.4	0.88	5.05	1	4.55
Accrued Expenses	2.38	3.55	10.78	12.92	9.06	3.49
Current Portion of Leases	3.64	3.39	2.89	2.35	2.11	0.94
Current Income Taxes Payable	0.07	0.03	0.13	0.04	-	0.56
Current Unearned Revenue	-	1.86	9.58	-	-	-
Other Current Liabilities	0.22	4.04	0.42	1.13	1.46	3.32
Total Current Liabilities	7.88	15.28	24.7	21.49	13.63	12.86
Long-Term Leases	20.45	21.51	25.38	28.74	31.65	31.12
Long-Term Unearned Revenue	-	-	4.13	-	-	-
Other Long-Term Liabilities	-	-	-	0.21	1.1	2.47
Total Liabilities	28.33	36.78	54.2	50.44	46.38	46.45
Common Stock	0.06	0.06	0.06	0.06	0.06	0.05
Additional Paid-In Capital	683.06	682.45	667.86	641.42	608.06	577.39
Retained Earnings	-603.3	-594.94	-508.86	-396.19	-262.98	-111.91
Comprehensive Income & Other	-	0.01	0.02	-0.79	-0.04	-0.02
Total Common Equity	79.81	87.58	159.08	244.5	345.1	465.52
Shareholders' Equity	79.81	87.58	159.08	244.5	345.1	465.52
Total Liabilities & Equity	108.14	124.36	213.28	294.94	391.48	511.96
Total Debt	24.09	24.9	28.27	31.09	33.76	32.06
Net Cash (Debt)	75.65	87.52	144.73	207.09	305.75	381
Net Cash Growth	-39.25%	-39.52%	-30.12%	-32.27%	-19.75%	315.71%
Net Cash Per Share	1.25	1.46	2.51	3.68	5.58	23.41
Filing Date Shares Outstanding	60.97	60.97	60.1	57.63	56.6	56.05
Total Common Shares Outstanding	60.97	60.46	58.95	56.97	55.7	54.07
Working Capital	93.99	99.95	154.08	222.81	333.93	406.95
Book Value Per Share	1.31	1.45	2.70	4.29	6.20	8.61
Tangible Book Value	79.81	87.58	159.08	244.5	345.1	465.52
Tangible Book Value Per Share	1.31	1.45	2.70	4.29	6.20	8.61
Machinery	0.37	8.28	8.84	9.15	8.8	5.84
Leasehold Improvements	4.13	4.14	8.7	9.35	9.34	8.96

Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q